Director · Valion Bio, Inc. · Tivic Health Systems, Inc.
Side
BUY
Value
$10K
Shares
10.0K
Price
$1.04
Executed
Apr 15, 2026
Disclosed
Apr 20, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Apr 15 executedApr 20, 2026 disclosed
TIVC · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Bolton Sheryle filed this Form 4 reporting a open-market purchase of TIVC on Apr 15, 2026. It became public on Apr 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Bolton Sherylecik:0001418947
Issuer
Valion Bio, Inc.cik:0001787740
Revision history · 0
No field has changed since this record was first ingested.
Company events
No records
No material filings recorded for this issuer.
Source error
Price history for TIVC is unavailable.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.
